Cargando…

Ribosomes: the future of targeted therapies?

Detalles Bibliográficos
Autores principales:	Marcel, Virginie, Catez, Frédéric, Diaz, Jean-Jacques
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	Editorial Material
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858544/ https://www.ncbi.nlm.nih.gov/pubmed/24145310

Ejemplares similares

Ribosome heterogeneity in tumorigenesis: the rRNA point of view
por: Marcel, Virginie, et al.
Publicado: (2015)

2′-O-Methylation of Ribosomal RNA: Towards an Epitranscriptomic Control of Translation?
por: Monaco, Piero Lo, et al.
Publicado: (2018)

Emerging Role of Eukaryote Ribosomes in Translational Control
por: Dalla Venezia, Nicole, et al.
Publicado: (2019)

Ribosome Biogenesis Alterations in Colorectal Cancer
por: Nait Slimane, Sophie, et al.
Publicado: (2020)

Expression Profiling of Ribosome Biogenesis Factors Reveals Nucleolin as a Novel Potential Marker to Predict Outcome in AML Patients
por: Marcel, Virginie, et al.
Publicado: (2017)

Therapy of hyperammonemia
por: Widera, Agata
Publicado: (2015)

Dopamine signaling: target in glioblastoma
por: Bartek, Jiri, et al.
Publicado: (2014)

Targeting IL-11 signaling in colon cancer
por: Ernst, Matthias, et al.
Publicado: (2013)

Targeting leukemia stem cells: in vitro veritas?
por: Bond, Heather M., et al.
Publicado: (2014)

Cancer research: from prognostic genes to therapeutic targets
por: Marchan, Rosemarie
Publicado: (2014)

Highlight report: Activating tumor-specific T-cells for breast cancer therapy
por: Gogiashvili, Mikheil
Publicado: (2018)

Ribosomal RNA 2′ O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer
por: Marcel, Virginie, et al.
Publicado: (2021)

Ribosomal RNA 2′O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer
por: Marcel, Virginie, et al.
Publicado: (2020)

2′O-Ribose Methylation of Ribosomal RNAs: Natural Diversity in Living Organisms, Biological Processes, and Diseases
por: Jaafar, Mariam, et al.
Publicado: (2021)

In vivo selection of tumor-specific antibodies
por: Sánchez-Martín, David, et al.
Publicado: (2013)

Estrogen response in luminal breast cancer
por: Rangel, Leticia B. A., et al.
Publicado: (2013)

IκBα beyond the NF-kB dogma
por: Mulero, Maria Carmen, et al.
Publicado: (2013)

Cytokine-induced ‘bystander’ senescence in DDR and immuno-surveillance
por: Hodny, Zdenek, et al.
Publicado: (2013)

CDK6 and p16(INK4A) in lymphoid malignancies
por: Kollmann, Karoline, et al.
Publicado: (2013)

Hexokinase 2 as oncotarget
por: Patra, Krushna C., et al.
Publicado: (2013)

MicroRNAs as regulators of tumor-associated stromal cells
por: Ell, Brian, et al.
Publicado: (2013)

MYC and MiR: vicious circle
por: Zhao, Xiaohong, et al.
Publicado: (2013)

Wip1 and ATM in tumor evolution: role for BRCA1
por: Filipponi, Doria, et al.
Publicado: (2013)

Plasticity of melanoma and EMT-TF reprogramming
por: Tulchinsky, Eugene, et al.
Publicado: (2013)

DNp73: oncotarget in invasion and metastasis
por: Pützer, Brigitte M.
Publicado: (2013)

Breaking Bad: how does a neuronal protein cause neuroendocrine cancer?
por: Pozo, Karine, et al.
Publicado: (2013)

Spherical nucleic acids for precision medicine
por: Mirkin, Chad A., et al.
Publicado: (2013)

Impact of Wikipedia on citation trends
por: Marashi, Sayed-Amir, et al.
Publicado: (2013)

Highlight report: Functional consequences of urinary bladder cancer risk variants
por: Selinski, Silvia
Publicado: (2013)

Influence of framing on medical decision making
por: Gong, Jingjing, et al.
Publicado: (2013)

Interaction of genetic variants towards increased cancer risk
por: Hammad, Seddik
Publicado: (2013)

Recent studies on flavonoids and their antioxidant activities
por: Chae, Soo Cheon, et al.
Publicado: (2013)

Neuroprotective effects of medicinal plants
por: Uddin, Romij, et al.
Publicado: (2013)

Improved genotyping of N-acetyltransferase 2: role of the ultra-slow acetylators
por: Blaszkewicz, Meinolf
Publicado: (2013)

Relevance of genetic disposition versus environmental exposure for cancer risk: an old controversy revisited with novel methods
por: Bolt, H.M.
Publicado: (2013)

Transcriptomics in developmental toxicity testing
por: Bolt, H. M.
Publicado: (2013)

Invasive leader cells: metastatic oncotarget
por: Cheung, Kevin J., et al.
Publicado: (2014)

Strigolactone analogues induce apoptosis through activation of p38 and the stress response pathway in cancer cell lines and in conditionally reprogramed primary prostate cancer cells.
por: Pollock, Claire B, et al.
Publicado: (2014)

IRAK1: oncotarget in MDS and AML
por: Beverly, Levi J., et al.
Publicado: (2014)

PTSD in the military: special considerations for understanding prevalence, pathophysiology and treatment following deployment
por: Yehuda, Rachel, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2uj41qn86i834acsjdjv1jq8ba